LicianPro

Matinas BioPharma Holdings, Inc. ·

MTNB 8-K 2026-09-28

Matinas BioPharma Holdings, Inc. (MTNB) 8-K dated 2026-09-28 — accession 0001493152-26-044451.

Matinas BioPharma Holdings, Inc. (MTNB) is a biotechnology company listed on US.

Matinas BioPharma Holdings, Inc. filed a 8-K on 2026-09-28. Accession 0001493152-26-044451.

This 8-K covers: Change to holders' rights (Item 3.03), Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MTNB revenue for 2023-09-30 was $1.1M. Net income was -$6.1M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. MTNB currently screens at market cap $5.6M.

Not investment advice. The MTNB SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr